619
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluation

Janumet: a combination product suitable for use in patients with Type 2 diabetes

, PharmD FASCP, , PharmD CGP FASCP & , RPh MBA CDE FASHP
Pages 1559-1565 | Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

André J Scheen. (2012) Saxagliptin plus metformin combination therapy. Expert Review of Endocrinology & Metabolism 7:2, pages 151-164.
Read now
Baptist Gallwitz. (2011) Sitagliptin and metformin combination therapy for the treatment of Type 2 diabetes. Expert Review of Endocrinology & Metabolism 6:4, pages 543-556.
Read now
André J Scheen. (2010) Pharmacokinetic and pharmacodynamic evaluation of sitagliptin plus metformin. Expert Opinion on Drug Metabolism & Toxicology 6:10, pages 1265-1276.
Read now
Jonathan K Reynolds. (2009) Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity 2, pages 127-134.
Read now

Articles from other publishers (9)

Kunika Saini, Smriti Sharma & Yousuf Khan. (2023) DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature. Frontiers in Molecular Biosciences 10.
Crossref
Qianni Cheng & Po Sing Leung. (2011) An update on the islet renin–angiotensin system. Peptides 32:5, pages 1087-1095.
Crossref
Julio RosenstockSilvio E. InzucchiJochen SeufertPenny R. FleckCraig A. WilsonQais Mekki. (2010) Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naïve Patients With Type 2 Diabetes. Diabetes Care 33:11, pages 2406-2408.
Crossref
André J. Scheen. (2010) Dipeptidylpeptitase-4 Inhibitors (Gliptins). Clinical Pharmacokinetics 49:9, pages 573-588.
Crossref
A. J. Scheen. (2010) Pharmacokinetics of dipeptidylpeptidase-4 inhibitors. Diabetes, Obesity and Metabolism 12:8, pages 648-658.
Crossref
Scott D. Edmondson, Feng Xu & Joseph D. ArmstrongIIIIII. 2010. Modern Drug Synthesis. Modern Drug Synthesis 123 140 .
Joshua J Neumiller, Lindy Wood & R. Keith Campbell. (2010) Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus. Pharmacotherapy 30:5, pages 463-484.
Crossref
D. Williams‐Herman, J. Johnson, R. Teng, G. Golm, K. D. Kaufman, B. J. Goldstein & J. M. Amatruda. (2010) Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes. Diabetes, Obesity and Metabolism 12:5, pages 442-451.
Crossref
Allison Wick & Kelley Newlin. (2009) Incretin-based therapies: Therapeutic rationale and pharmacological promise for type 2 diabetes. Journal of the American Academy of Nurse Practitioners 21, pages 623-630.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.